Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Mantle Cell Lymphoma Therapeutics Revenue 1.4 Market Analysis by Type 1.4.1 Global Mantle Cell Lymphoma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Combination Therapy 1.4.3 Monotherapy 1.5 Market by Application 1.5.1 Global Mantle Cell Lymphoma Therapeutics Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Research Institute 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Mantle Cell Lymphoma Therapeutics Market Perspective (2015-2026) 2.2 Mantle Cell Lymphoma Therapeutics Growth Trends by Regions 2.2.1 Mantle Cell Lymphoma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Mantle Cell Lymphoma Therapeutics Historic Market Share by Regions (2015-2020) 2.2.3 Mantle Cell Lymphoma Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Mantle Cell Lymphoma Therapeutics Market Growth Strategy 2.3.6 Primary Interviews with Key Mantle Cell Lymphoma Therapeutics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Mantle Cell Lymphoma Therapeutics Players by Market Size 3.1.1 Global Top Mantle Cell Lymphoma Therapeutics Players by Revenue (2015-2020) 3.1.2 Global Mantle Cell Lymphoma Therapeutics Revenue Market Share by Players (2015-2020) 3.1.3 Global Mantle Cell Lymphoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Mantle Cell Lymphoma Therapeutics Market Concentration Ratio 3.2.1 Global Mantle Cell Lymphoma Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Mantle Cell Lymphoma Therapeutics Revenue in 2019 3.3 Mantle Cell Lymphoma Therapeutics Key Players Head office and Area Served 3.4 Key Players Mantle Cell Lymphoma Therapeutics Product Solution and Service 3.5 Date of Enter into Mantle Cell Lymphoma Therapeutics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Mantle Cell Lymphoma Therapeutics Historic Market Size by Type (2015-2020) 4.2 Global Mantle Cell Lymphoma Therapeutics Forecasted Market Size by Type (2021-2026) 5 Mantle Cell Lymphoma Therapeutics Breakdown Data by Application (2015-2026) 5.1 Global Mantle Cell Lymphoma Therapeutics Market Size by Application (2015-2020) 5.2 Global Mantle Cell Lymphoma Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Mantle Cell Lymphoma Therapeutics Market Size (2015-2020) 6.2 Mantle Cell Lymphoma Therapeutics Key Players in North America (2019-2020) 6.3 North America Mantle Cell Lymphoma Therapeutics Market Size by Type (2015-2020) 6.4 North America Mantle Cell Lymphoma Therapeutics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Mantle Cell Lymphoma Therapeutics Market Size (2015-2020) 7.2 Mantle Cell Lymphoma Therapeutics Key Players in Europe (2019-2020) 7.3 Europe Mantle Cell Lymphoma Therapeutics Market Size by Type (2015-2020) 7.4 Europe Mantle Cell Lymphoma Therapeutics Market Size by Application (2015-2020) 8 China 8.1 China Mantle Cell Lymphoma Therapeutics Market Size (2015-2020) 8.2 Mantle Cell Lymphoma Therapeutics Key Players in China (2019-2020) 8.3 China Mantle Cell Lymphoma Therapeutics Market Size by Type (2015-2020) 8.4 China Mantle Cell Lymphoma Therapeutics Market Size by Application (2015-2020) 9 Japan 9.1 Japan Mantle Cell Lymphoma Therapeutics Market Size (2015-2020) 9.2 Mantle Cell Lymphoma Therapeutics Key Players in Japan (2019-2020) 9.3 Japan Mantle Cell Lymphoma Therapeutics Market Size by Type (2015-2020) 9.4 Japan Mantle Cell Lymphoma Therapeutics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size (2015-2020) 10.2 Mantle Cell Lymphoma Therapeutics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size by Type (2015-2020) 10.4 Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size by Application (2015-2020) 11 India 11.1 India Mantle Cell Lymphoma Therapeutics Market Size (2015-2020) 11.2 Mantle Cell Lymphoma Therapeutics Key Players in India (2019-2020) 11.3 India Mantle Cell Lymphoma Therapeutics Market Size by Type (2015-2020) 11.4 India Mantle Cell Lymphoma Therapeutics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Mantle Cell Lymphoma Therapeutics Market Size (2015-2020) 12.2 Mantle Cell Lymphoma Therapeutics Key Players in Central & South America (2019-2020) 12.3 Central & South America Mantle Cell Lymphoma Therapeutics Market Size by Type (2015-2020) 12.4 Central & South America Mantle Cell Lymphoma Therapeutics Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Allergan Plc 13.1.1 Allergan Plc Company Details 13.1.2 Allergan Plc Business Overview and Its Total Revenue 13.1.3 Allergan Plc Mantle Cell Lymphoma Therapeutics Introduction 13.1.4 Allergan Plc Revenue in Mantle Cell Lymphoma Therapeutics Business (2015-2020)) 13.1.5 Allergan Plc Recent Development 13.2 AstraZeneca Plc 13.2.1 AstraZeneca Plc Company Details 13.2.2 AstraZeneca Plc Business Overview and Its Total Revenue 13.2.3 AstraZeneca Plc Mantle Cell Lymphoma Therapeutics Introduction 13.2.4 AstraZeneca Plc Revenue in Mantle Cell Lymphoma Therapeutics Business (2015-2020) 13.2.5 AstraZeneca Plc Recent Development 13.3 Celgene Corp. 13.3.1 Celgene Corp. Company Details 13.3.2 Celgene Corp. Business Overview and Its Total Revenue 13.3.3 Celgene Corp. Mantle Cell Lymphoma Therapeutics Introduction 13.3.4 Celgene Corp. Revenue in Mantle Cell Lymphoma Therapeutics Business (2015-2020) 13.3.5 Celgene Corp. Recent Development 13.4 Johnson & Johnson Services Inc. 13.4.1 Johnson & Johnson Services Inc. Company Details 13.4.2 Johnson & Johnson Services Inc. Business Overview and Its Total Revenue 13.4.3 Johnson & Johnson Services Inc. Mantle Cell Lymphoma Therapeutics Introduction 13.4.4 Johnson & Johnson Services Inc. Revenue in Mantle Cell Lymphoma Therapeutics Business (2015-2020) 13.4.5 Johnson & Johnson Services Inc. Recent Development 13.5 Takeda Pharmaceutical Co. Ltd. 13.5.1 Takeda Pharmaceutical Co. Ltd. Company Details 13.5.2 Takeda Pharmaceutical Co. Ltd. Business Overview and Its Total Revenue 13.5.3 Takeda Pharmaceutical Co. Ltd. Mantle Cell Lymphoma Therapeutics Introduction 13.5.4 Takeda Pharmaceutical Co. Ltd. Revenue in Mantle Cell Lymphoma Therapeutics Business (2015-2020) 13.5.5 Takeda Pharmaceutical Co. Ltd. Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Mantle Cell Lymphoma Therapeutics Key Market Segments Table 2. Key Players Covered: Ranking by Mantle Cell Lymphoma Therapeutics Revenue Table 3. Ranking of Global Top Mantle Cell Lymphoma Therapeutics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Mantle Cell Lymphoma Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Combination Therapy Table 6. Key Players of Monotherapy Table 7. Global Mantle Cell Lymphoma Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Mantle Cell Lymphoma Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Mantle Cell Lymphoma Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Mantle Cell Lymphoma Therapeutics Market Share by Regions (2015-2020) Table 11. Global Mantle Cell Lymphoma Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Mantle Cell Lymphoma Therapeutics Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Mantle Cell Lymphoma Therapeutics Market Growth Strategy Table 17. Main Points Interviewed from Key Mantle Cell Lymphoma Therapeutics Players Table 18. Global Mantle Cell Lymphoma Therapeutics Revenue by Players (2015-2020) (Million US$) Table 19. Global Mantle Cell Lymphoma Therapeutics Market Share by Players (2015-2020) Table 20. Global Top Mantle Cell Lymphoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mantle Cell Lymphoma Therapeutics as of 2019) Table 21. Global Mantle Cell Lymphoma Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Mantle Cell Lymphoma Therapeutics Product Solution and Service Table 24. Date of Enter into Mantle Cell Lymphoma Therapeutics Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Mantle Cell Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$) Table 27. Global Mantle Cell Lymphoma Therapeutics Market Size Share by Type (2015-2020) Table 28. Global Mantle Cell Lymphoma Therapeutics Revenue Market Share by Type (2021-2026) Table 29. Global Mantle Cell Lymphoma Therapeutics Market Size Share by Application (2015-2020) Table 30. Global Mantle Cell Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$) Table 31. Global Mantle Cell Lymphoma Therapeutics Market Size Share by Application (2021-2026) Table 32. North America Key Players Mantle Cell Lymphoma Therapeutics Revenue (2019-2020) (Million US$) Table 33. North America Key Players Mantle Cell Lymphoma Therapeutics Market Share (2019-2020) Table 34. North America Mantle Cell Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$) Table 35. North America Mantle Cell Lymphoma Therapeutics Market Share by Type (2015-2020) Table 36. North America Mantle Cell Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$) Table 37. North America Mantle Cell Lymphoma Therapeutics Market Share by Application (2015-2020) Table 38. Europe Key Players Mantle Cell Lymphoma Therapeutics Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Mantle Cell Lymphoma Therapeutics Market Share (2019-2020) Table 40. Europe Mantle Cell Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$) Table 41. Europe Mantle Cell Lymphoma Therapeutics Market Share by Type (2015-2020) Table 42. Europe Mantle Cell Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$) Table 43. Europe Mantle Cell Lymphoma Therapeutics Market Share by Application (2015-2020) Table 44. China Key Players Mantle Cell Lymphoma Therapeutics Revenue (2019-2020) (Million US$) Table 45. China Key Players Mantle Cell Lymphoma Therapeutics Market Share (2019-2020) Table 46. China Mantle Cell Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$) Table 47. China Mantle Cell Lymphoma Therapeutics Market Share by Type (2015-2020) Table 48. China Mantle Cell Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$) Table 49. China Mantle Cell Lymphoma Therapeutics Market Share by Application (2015-2020) Table 50. Japan Key Players Mantle Cell Lymphoma Therapeutics Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Mantle Cell Lymphoma Therapeutics Market Share (2019-2020) Table 52. Japan Mantle Cell Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$) Table 53. Japan Mantle Cell Lymphoma Therapeutics Market Share by Type (2015-2020) Table 54. Japan Mantle Cell Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$) Table 55. Japan Mantle Cell Lymphoma Therapeutics Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Mantle Cell Lymphoma Therapeutics Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Mantle Cell Lymphoma Therapeutics Market Share (2019-2020) Table 58. Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Mantle Cell Lymphoma Therapeutics Market Share by Type (2015-2020) Table 60. Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Mantle Cell Lymphoma Therapeutics Market Share by Application (2015-2020) Table 62. India Key Players Mantle Cell Lymphoma Therapeutics Revenue (2019-2020) (Million US$) Table 63. India Key Players Mantle Cell Lymphoma Therapeutics Market Share (2019-2020) Table 64. India Mantle Cell Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$) Table 65. India Mantle Cell Lymphoma Therapeutics Market Share by Type (2015-2020) Table 66. India Mantle Cell Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$) Table 67. India Mantle Cell Lymphoma Therapeutics Market Share by Application (2015-2020) Table 68. Central & South America Key Players Mantle Cell Lymphoma Therapeutics Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Mantle Cell Lymphoma Therapeutics Market Share (2019-2020) Table 70. Central & South America Mantle Cell Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Mantle Cell Lymphoma Therapeutics Market Share by Type (2015-2020) Table 72. Central & South America Mantle Cell Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Mantle Cell Lymphoma Therapeutics Market Share by Application (2015-2020) Table 74. Allergan Plc Company Details Table 75. Allergan Plc Business Overview Table 76. Allergan Plc Product Table 77. Allergan Plc Revenue in Mantle Cell Lymphoma Therapeutics Business (2015-2020) (Million US$) Table 78. Allergan Plc Recent Development Table 79. AstraZeneca Plc Company Details Table 80. AstraZeneca Plc Business Overview Table 81. AstraZeneca Plc Product Table 82. AstraZeneca Plc Revenue in Mantle Cell Lymphoma Therapeutics Business (2015-2020) (Million US$) Table 83. AstraZeneca Plc Recent Development Table 84. Celgene Corp. Company Details Table 85. Celgene Corp. Business Overview Table 86. Celgene Corp. Product Table 87. Celgene Corp. Revenue in Mantle Cell Lymphoma Therapeutics Business (2015-2020) (Million US$) Table 88. Celgene Corp. Recent Development Table 89. Johnson & Johnson Services Inc. Company Details Table 90. Johnson & Johnson Services Inc. Business Overview Table 91. Johnson & Johnson Services Inc. Product Table 92. Johnson & Johnson Services Inc. Revenue in Mantle Cell Lymphoma Therapeutics Business (2015-2020) (Million US$) Table 93. Johnson & Johnson Services Inc. Recent Development Table 94. Takeda Pharmaceutical Co. Ltd. Company Details Table 95. Takeda Pharmaceutical Co. Ltd. Business Overview Table 96. Takeda Pharmaceutical Co. Ltd. Product Table 97. Takeda Pharmaceutical Co. Ltd. Revenue in Mantle Cell Lymphoma Therapeutics Business (2015-2020) (Million US$) Table 98. Takeda Pharmaceutical Co. Ltd. Recent Development Table 99. Research Programs/Design for This Report Table 100. Key Data Information from Secondary Sources Table 101. Key Data Information from Primary Sources List of Figures Figure 1. Global Mantle Cell Lymphoma Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. Combination Therapy Features Figure 3. Monotherapy Features Figure 4. Global Mantle Cell Lymphoma Therapeutics Market Share by Application: 2020 VS 2026 Figure 5. Hospital Case Studies Figure 6. Research Institute Case Studies Figure 7. Other Case Studies Figure 8. Mantle Cell Lymphoma Therapeutics Report Years Considered Figure 9. Global Mantle Cell Lymphoma Therapeutics Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Mantle Cell Lymphoma Therapeutics Market Share by Regions: 2020 VS 2026 Figure 11. Global Mantle Cell Lymphoma Therapeutics Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Mantle Cell Lymphoma Therapeutics Market Share by Players in 2019 Figure 14. Global Top Mantle Cell Lymphoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mantle Cell Lymphoma Therapeutics as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Mantle Cell Lymphoma Therapeutics Revenue in 2019 Figure 16. North America Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Allergan Plc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Allergan Plc Revenue Growth Rate in Mantle Cell Lymphoma Therapeutics Business (2015-2020) Figure 25. AstraZeneca Plc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. AstraZeneca Plc Revenue Growth Rate in Mantle Cell Lymphoma Therapeutics Business (2015-2020) Figure 27. Celgene Corp. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Celgene Corp. Revenue Growth Rate in Mantle Cell Lymphoma Therapeutics Business (2015-2020) Figure 29. Johnson & Johnson Services Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Johnson & Johnson Services Inc. Revenue Growth Rate in Mantle Cell Lymphoma Therapeutics Business (2015-2020) Figure 31. Takeda Pharmaceutical Co. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Takeda Pharmaceutical Co. Ltd. Revenue Growth Rate in Mantle Cell Lymphoma Therapeutics Business (2015-2020) Figure 33. Bottom-up and Top-down Approaches for This Report Figure 34. Data Triangulation Figure 35. Key Executives Interviewed

Allergan Plc AstraZeneca Plc Celgene Corp. Johnson & Johnson Services Inc. Takeda Pharmaceutical Co. Ltd.